AN2 Therapeutics, Inc. Common Stock (ANTX) is a publicly traded Healthcare sector company. As of November 2, 2026, ANTX trades at $5.08 with a market cap of $170.95M and a P/E ratio of -2.98. ANTX moved +12.05% today. Year to date, ANTX is +308.11%; over the trailing twelve months it is +265.32%. Its 52-week range spans $1.00 to $7.19. Rallies surfaces ANTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ANTX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $5.08 |
| Market Cap | $170.95M |
| P/E Ratio | -2.98 |
| EPS | $-1.72 |
| Dividend Yield | 0.66% |
| 52-Week High | $7.19 |
| 52-Week Low | $1.00 |
| Volume | 7.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-51.32M |
| Gross Margin | 0.00% |
ANTX analyst coverage data. Average price target: $0.00.